Skip to main content
. 2023 Jul 3;21:430. doi: 10.1186/s12967-023-04250-z

Table 6.

Scores of symptoms scale of spleen-kidney Yang deficiency in the end of treatment

Items Group A (n = 30) Group B (n = 30) Median/MD (95%CI) P-value
Fear of cold and cold extremities 2.00 (1.50, 4.00) 4.00 (2.00, 4.00) 0.00 (− 2.00, 0.00) 0.034*
Lassitude and lack of strength 2.00 (2.00, 2.50) 2.00 (2.00, 2.00) 0.00 (0.00, 0.00) 0.290
Shortness of breath and laziness to speak 2.00 (0.00, 2.00) 2.00 (2.00, 2.00) 0.00 (− 1.00, 0.00) 0.045*
Reduced food intake 0.00 (0.00, 1.25) 0.00 (0.00, 2.00) 0.00 (− 1.00, 0.00) 0.072
Soreness and weakness of waist and knees 0.00 (0.00, 2.00) 2.00 (0.00, 2.00) 0.00 (− 2.00, 0.00) 0.033*
Lumbar cold pain 1.00 (0.00, 1.00) 1.00 (0.00, 2.00) 0.00 (− 1.00, 0.00) 0.028*
Abdominal fullness and distention 1.00 (0.00, 1.00) 1.00 (1.00, 1.00) 0.00 (− 1.00, 0.00) 0.173
Loose stool 0.00 (0.00, 1.00) 1.00 (0.00, 1.00) 0.00 (− 1.00, 0.00) 0.028*
Cold and more urine volume during night 0.00 (0.00, 1.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.046*
Total score 9.80 (4.37) 13.07 (5.29) − 3.27 (− 5.78, − 0.76) 0.012*

Independent sample T test (for total score) and Mann-Whitney U test (for non-normally distributed items) were used for comparing differences between groups to obtain P-values; Hodges-Lehmann method was used to calculate median differences and their 95% confidence intervals. Group A: Long-snake-like moxibustion for 60 min; Group B: Long-snake-like moxibustion for 30 min; Data were presented as mean ± standard deviation (SD) and Median (Q1, Q3); Q: quarter; Q1: 25th percentile; Q3: 75th percentile

MD mean difference; 95%CI 95% Confidence Interval

* p < 0.05